Heparin Sodium Injection
Hospira, Inc., a Pfizer Company · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 11/14/2017
- Package NDC
- 0409-2222-12
- Generic name
- Heparin Sodium Injection
- Contact info
- 844-646-4398
- Availability
- Available
- Update date
- 09/22/2026
- Dosage form
- Injection
- Presentation
- Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)
- Company name
- Hospira, Inc., a Pfizer Company
- Status
- Current
- Therapeutic category
- Hematology
- Harmonized identifiers (openFDA)
- Application number
- NDA018916
- Brand name
- HEPARIN SODIUM
- Generic name
- HEPARIN SODIUM
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-2222, 0409-7620, 0409-1005
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- HEPARIN SODIUM
- RxCUI
- 1658690, 1658691, 1658692
- SPL ID
- ecaae7d2-a76e-4eca-b045-6c88d7c2ab8f
- SPL set ID
- 32e34077-aff1-4ec7-f9b0-b8e240768fb8
- Package NDC
- 0409-7620-13, 0409-7620-03, 0409-7620-49, 0409-7620-59, 0409-1005-01, 0409-1005-20, 0409-2222-01, 0409-2222-12
- UNII
- ZZ45AB24CA